Cutera Beheer

Beheer criteriumcontroles 0/4

De CEO Cutera is Taylor Harris, benoemd in Aug2023, heeft een ambtstermijn van 1.25 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 7.69M, bestaande uit 3.5% salaris en 96.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.44% van de aandelen van het bedrijf, ter waarde $ 28.16K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.3 jaar en 1.5 jaar.

Belangrijke informatie

Taylor Harris

Algemeen directeur

US$7.7m

Totale compensatie

Percentage CEO-salaris	3.5%
Dienstverband CEO	1.3yrs
Eigendom CEO	0.4%
Management gemiddelde ambtstermijn	1.3yrs
Gemiddelde ambtstermijn bestuur	1.5yrs

Recente managementupdates

Recent updates

Cutera, Inc. (NASDAQ:CUTR) Looks Inexpensive After Falling 47% But Perhaps Not Attractive Enough

Aug 20

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 28% Dive

Jun 22

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 35% Dive

Mar 14

Analysts Are More Bearish On Cutera, Inc. (NASDAQ:CUTR) Than They Used To Be

Aug 11

An Intrinsic Calculation For Cutera, Inc. (NASDAQ:CUTR) Suggests It's 48% Undervalued

Apr 19

Cutera, Inc. (NASDAQ:CUTR) Shares Could Be 49% Below Their Intrinsic Value Estimate

Sep 01

Cutera: The 'AviClear' Sign To Get Bullish

Jun 22

Cutera (NASDAQ:CUTR) Is Carrying A Fair Bit Of Debt

May 27

Analyse CEO-vergoeding

Hoe is Taylor Harris's beloning veranderd ten opzichte van Cutera's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-US$144m
Jun 30 2024	n/a	n/a	-US$149m
Mar 31 2024	n/a	n/a	-US$158m
Dec 31 2023	US$8m	US$271k	-US$163m

Compensatie versus markt: De totale vergoeding ($USD 7.69M ) Taylor } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 649.07K ).

Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Taylor te vergelijken met de prestaties van het bedrijf.

CEO

Taylor Harris (48 yo)

1.3yrs

Tenure

US$7,685,535

Compensatie

Mr. Taylor C. Harris serves as Director of Omada Health, Inc. since February 2022. He serves as Advisor at Lauxera Capital Partners. Mr. Harris has been an Independent Director at HealthCor Catalio Acquisi...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Taylor Harris	President	1.3yrs	US$7.69m	0.44% $ 28.2k
Stuart Drummond	Chief Financial Officer	1.5yrs	US$777.83k	0.088% $ 5.6k
Jeffrey Jones	Chief Operating Officer	1.3yrs	US$541.00k	geen gegevens
Stephana Patton	Chief Legal Officer	less than a year	US$347.73k	0.020% $ 1.3k
Charles Thier	Chief Information Officer	5.1yrs	US$1.86m	geen gegevens
Greg Barker	Vice President of FP&A and Investor Relations	no data	geen gegevens	geen gegevens
Steve Kreider	Senior Vice President of Global Marketing	2.8yrs	geen gegevens	geen gegevens
Brent Hauser	President of International	1.1yrs	geen gegevens	geen gegevens
Shelby Eckerman	Vice President of Finance	no data	geen gegevens	geen gegevens

1.3yrs

Gemiddelde duur

55.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CUTR wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.3 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Taylor Harris	President	1.5yrs	US$7.69m	0.44% $ 28.2k
Jeryl Hilleman	Director	less than a year	geen gegevens	geen gegevens
Kevin Cameron	Independent Chairman	1.5yrs	US$285.40k	geen gegevens
Keith Sullivan	Independent Director	1.5yrs	US$220.05k	0.020% $ 1.3k
Nicholas Lewin	Independent Director	1.5yrs	US$268.79k	geen gegevens

1.5yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CUTR wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.5 jaar), wat duidt op een nieuw bestuur.

Cutera Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

High number of new and inexperienced directors

High number of new and inexperienced directors

Cutera, Inc., Annual General Meeting, Jul 15, 2024

High number of new and inexperienced directors

Cutera, Inc. Announces Resignation of Juliane Park from the Board of Directors, Effective as of December 1, 2023

Janet Widmann Resigns from the Board of Directors of Cutera, Inc. Effective November 1, 2023

Recent updates

Cutera Receives Deficiency Notice from Nasdaq Regarding Minimum $15 Million Market Value of Publicly Held Shares Requirement under Nasdaq Marketplace Rule 5450(b)(3)(C)

Consensus EPS estimates fall by 16%

Third quarter 2024 earnings: EPS misses analyst expectations

New major risk - Market cap size

Cutera, Inc. Reaffirms Financial Guidance for the Full Year 2024

Cutera, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Cutera Receives Deficiency Notice from Nasdaq Regarding Listing Rule 5450(a)(1)

Cutera, Inc. (NASDAQ:CUTR) Looks Inexpensive After Falling 47% But Perhaps Not Attractive Enough

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Cutera, Inc. Revises Revenue Guidance for the Year 2024

High number of new and inexperienced directors

Cutera, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Cutera, Inc.(NasdaqGS:CUTR) dropped from Russell 3000 Index

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 28% Dive

Price target decreased by 17% to US$6.33

High number of new and inexperienced directors

Cutera, Inc., Annual General Meeting, Jul 15, 2024

Cutera, Inc. Reiterates Earnings Guidance for 2024

Cutera, Inc. to Report Q1, 2024 Results on May 09, 2024

Cutera, Inc. Announces North America Launch of xeo+

Cutera, Inc. Provides Revenue Guidance for the Full Year 2024

Cutera, Inc. announced delayed annual 10-K filing

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 35% Dive

Consensus EPS estimates fall by 33%

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Cutera, Inc. to Report Q4, 2023 Results on Mar 21, 2024

Price target decreased by 59% to US$7.67

High number of new and inexperienced directors

Cutera, Inc. Revises Revenue Guidance for the Full Year 2023

Cutera, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-Q

Cutera, Inc. announced delayed 10-Q filing

Cutera, Inc. Announces Resignation of Juliane Park from the Board of Directors, Effective as of December 1, 2023

Cutera, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Janet Widmann Resigns from the Board of Directors of Cutera, Inc. Effective November 1, 2023

New minor risk - Market cap size

Cutera, Inc. Appoints Brent Hauser as President, International

Cutera, Inc. Announces the Launch of New Skin Resurfacing and Revitalization Platform Secret DUO

President recently bought US$297k worth of stock

Cutera, Inc. Appoints Jeffrey Jones as Chief Operating Officer, Effective August 28, 2023

Consensus revenue estimates fall by 14%

Analysts Are More Bearish On Cutera, Inc. (NASDAQ:CUTR) Than They Used To Be

New major risk - Share price stability

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 8.9% to US$23.00

Cutera, Inc. Provides Revenue Guidance for the Full Year 2023

Cutera, Inc. Appoints Talyor C. Harris as President, Effective August 7, 2023

Cutera, Inc. Announces CEO Changes, Effective August 7, 2023

Cutera, Inc. to Report Q2, 2023 Results on Aug 08, 2023

the Gross Law Firm Notifies Shareholders of Cutera, Inc. of A Class Action Lawsuit and A Lead Plaintiff Deadline of July 24, 2023

Cutera, Inc. Announces A New U.S. Food and Drug Administration Clearance of AviClear as A Long-Term Treatment for Mild to Severe Inflammatory Acne Vulgaris

Cutera, Inc. Announces Resignation of J. Daniel Plants as Director

Independent Director notifies of intention to sell stock

Cutera, Inc. Announces Resignation of Joseph E. Whitters from the Board of Directors

Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against Cutera, Inc

Less than half of directors are independent

Cutera, Inc. Announces Board Changes

Cutera, Inc. Appoints Stuart Drummond as Interim Chief Financial Officer

Voce Capital and David Mowry Terminate Proxy Solicitation

Cutera, Inc. Announces Chief Financial Officer Changes

First quarter 2023 earnings: EPS and revenues miss analyst expectations

An Intrinsic Calculation For Cutera, Inc. (NASDAQ:CUTR) Suggests It's 48% Undervalued

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 57%

Now 21% undervalued after recent price drop

Full year 2022 earnings: EPS misses analyst expectations

Does Cutera (NASDAQ:CUTR) Have A Healthy Balance Sheet?

Price target decreased to US$61.20

Cutera, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Cutera, Inc. Announces AviClear™ Now Broadly Available to US Physicians and Practitioners Upon National Launch